AIMS: The risk factors associated with poor prognosis of nonalcoholic fatty liver disease (NAFLD) are not fully understood. Our aim was to assess the role of progressive hepatocellular telomere shortening in the clinical course of NAFLD. METHODS: We measured average telomere lengths in liver tissue samples from 44 patients with NAFLD by quantitative fluorescence in situ hybridization using a telomere-specific probe. Patients in which telomeres measured at least 80% of the lengths of age-matched controls were categorized as group A. Those patients with telomeres measuring less than 80% of the control lengths formed group B. RESULTS: Within group B, some samples showed a remarkable shortening of hepatocyte telomeres in younger patients, whereas some group A patients showed almost normal telomere lengths until their seventies. Among clinicopathological factors, body mass index (BMI), homeostasis model assessment insulin resistance (HOMA-IR), histological degree of steatosis and intensity of 8-hydroxy-2'-deoxyguanosine (8-OHdG) immunostaining were all significantly higher in group B than in group A. Ki-67 immunohistochemistry demonstrated that group B liver tissues were significantly less proliferative than those from group A, despite no significant difference in the necroinflammatory activities of group A and B samples. In group B patients, the ratios of Ki-67 positive index to alanine aminotransferase value were significantly lower than group A. CONCLUSIONS: Greater insulin resistance can result in more severe hepatic steatosis among group B patients, leading to an overproduction of reactive oxygen species, which may accelerate telomere erosion. Furthermore the regenerative response of hepatocytes with prominent telomere shortening may be impaired, making these cells vulnerable to the effect of a 'second-hit' insult.
AIMS: The risk factors associated with poor prognosis of nonalcoholic fatty liver disease (NAFLD) are not fully understood. Our aim was to assess the role of progressive hepatocellular telomere shortening in the clinical course of NAFLD. METHODS: We measured average telomere lengths in liver tissue samples from 44 patients with NAFLD by quantitative fluorescence in situ hybridization using a telomere-specific probe. Patients in which telomeres measured at least 80% of the lengths of age-matched controls were categorized as group A. Those patients with telomeres measuring less than 80% of the control lengths formed group B. RESULTS: Within group B, some samples showed a remarkable shortening of hepatocyte telomeres in younger patients, whereas some group A patients showed almost normal telomere lengths until their seventies. Among clinicopathological factors, body mass index (BMI), homeostasis model assessment insulin resistance (HOMA-IR), histological degree of steatosis and intensity of 8-hydroxy-2'-deoxyguanosine (8-OHdG) immunostaining were all significantly higher in group B than in group A. Ki-67 immunohistochemistry demonstrated that group B liver tissues were significantly less proliferative than those from group A, despite no significant difference in the necroinflammatory activities of group A and B samples. In group B patients, the ratios of Ki-67 positive index to alanine aminotransferase value were significantly lower than group A. CONCLUSIONS: Greater insulin resistance can result in more severe hepatic steatosis among group B patients, leading to an overproduction of reactive oxygen species, which may accelerate telomere erosion. Furthermore the regenerative response of hepatocytes with prominent telomere shortening may be impaired, making these cells vulnerable to the effect of a 'second-hit' insult.
Authors: Xiaoling Jin; Teresa A Zimmers; Yanlin Jiang; Daniel P Milgrom; Zongxiu Zhang; Leonidas G Koniaris Journal: Surgery Date: 2018-02-01 Impact factor: 3.982
Authors: Katharine M Irvine; Richard Skoien; Nilesh J Bokil; Michelle Melino; Gethin P Thomas; Dorothy Loo; Brian Gabrielli; Michelle M Hill; Matthew J Sweet; Andrew D Clouston; Elizabeth E Powell Journal: World J Gastroenterol Date: 2014-12-21 Impact factor: 5.742
Authors: Aloysious Aravinthan; George Mells; Michael Allison; Julian Leathart; Anna Kotronen; Hannele Yki-Jarvinen; Ann K Daly; Christopher P Day; Quentin M Anstee; Graeme Alexander Journal: Cell Cycle Date: 2014-03-11 Impact factor: 4.534
Authors: Muraly Puttabyatappa; Joseph N Ciarelli; Adam G Chatoff; Vasantha Padmanabhan Journal: Mol Cell Endocrinol Date: 2021-02-17 Impact factor: 4.102
Authors: Nai-Chieh Y You; Brian H Chen; Yiqing Song; XuYang Lu; Yilin Chen; JoAnn E Manson; Mo Kang; Barbara V Howard; Karen L Margolis; J David Curb; Lawrence S Phillips; Marcia L Stefanick; Lesley F Tinker; Simin Liu Journal: Diabetes Date: 2012-07-24 Impact factor: 9.461